Back to top

Impact of ethnicity on the development of kidney disease

Impact of ethnicity on the development of kidney disease in the UK, a retrospective database study

What we are doing:

We will use anonymised information gathered as part of a kidney study to examine how common long-term kidney disease is in people from different ethnic backgrounds. We will use the most up-to-date method to calculate kidney function, as well as examine how many people with kidney disease are already known to their GPs. We will also plan to meet up with people from different ethnic groups to explore any underlying cultural differences in how kidney disease is perceived. This will enable us to start designing services to become more accessible for people from different ethnic groups. 

Why we are doing it:

Long-term kidney weakness affects up to 10% of adults in the UK. We know very little about the number of people from non-white ethnicities suffering from long-standing kidney weakness, or if they are receiving adequate medical care for their condition. As the UK becomes more and more ethnically diverse, we feel it is important to study this area, so that the NHS can ensure everyone is getting equal care for kidney disease, regardless of ethnic background.  

What the benefits will be:

We aim to identify if any ethnic group has a higher proportion of people with long-standing kidney weakness then the white population, this will allow doctors to better allocate resources in the future. If we identify any underlying weakness in the way kidney disease is currently diagnosed in the community we will work with local managers to change the way doctors work. Understanding if there are any cultural differences in the way different ethnic groups view kidney disease will allow doctors to develop better educational material for people to help improve their health.  

Who we are working with:

We are working with the Real-World Evidence Unit at the University of Leicester and the East Midlands Centre for Black and Minority Ethnic Health.

Study lead:

Name: Dr Gang Xu

Role: Consultant Nephrologist 

Organisation: University Hospitals of Leicester NHS Trust


Dr Gang Xu,